ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 410 filers reported holding ENCOMPASS HEALTH CORP in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,820,417 | -26.3% | 726,927 | -25.7% | 0.90% | -24.3% |
| Q2 2023 | $66,241,506 | +14.7% | 978,312 | -8.4% | 1.19% | +8.6% |
| Q1 2023 | $57,764,842 | -2.8% | 1,067,742 | +7.5% | 1.10% | -36.5% |
| Q4 2022 | $59,421,594 | +19.5% | 993,506 | -9.6% | 1.73% | -13.4% |
| Q3 2022 | $49,715,000 | -23.3% | 1,099,171 | -4.9% | 2.00% | -14.0% |
| Q2 2022 | $64,790,000 | -17.5% | 1,155,944 | +4.7% | 2.33% | -3.0% |
| Q1 2022 | $78,538,000 | +48.4% | 1,104,443 | +36.2% | 2.40% | +46.5% |
| Q4 2021 | $52,910,000 | +69.7% | 810,768 | +95.1% | 1.64% | +46.2% |
| Q3 2021 | $31,183,000 | +13.8% | 415,550 | +18.3% | 1.12% | +14.5% |
| Q2 2021 | $27,404,000 | +1.1% | 351,201 | +6.1% | 0.98% | -21.3% |
| Q1 2021 | $27,109,000 | +64.2% | 330,997 | +65.7% | 1.24% | +29.9% |
| Q4 2020 | $16,513,000 | – | 199,697 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |